Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

16

Number of overlapping holdings

57.1%

% of PBE's 28 holdings also in BBP

26.2%

% of BBP's 65 holdings also in PBE

Overlap by Weight
Sector Drift (PBE minus BBP)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in BBP
Overlap
ACADIA PHARMACEUTICALS INC 2.9% 1.9% 1.9%
BIOCRYST PHARMACEUTICALS INC 2.9% 1.8% 1.8%
TG THERAPEUTICS INC 2.6% 1.8% 1.8%
GILEAD SCIENCES INC 5.1% 1.8% 1.8%
AXSOME THERAPEUTICS, INC. 2.6% 1.7% 1.7%

Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to BBP
NATERA INC 5.1%
ILLUMINA INC 5.1%
BIOGEN IDEC INC 3.5%
REGENERON PHARMACEUTICALS 3.4%
GILEAD SCIENCES INC 3.4%
UNITED THERAPEUTICS CORP 3.3%
INCYTE CORP 3.1%
EXACT SCIENCES CORP 3.1%
AMGEN INC 3.0%
VERACYTE INC 2.9%
PBE Underweight Relative to BBP
MIRUM PHARMACEUTICALS, INC. -2.4%
ALNYLAM PHARMACEUTICALS INC -2.1%
TRAVERE THERAPEUTICS, INC. -2.0%
LIGAND PHARMACEUTICALS-CL B -1.9%
LEXICON PHARMACEUTICALS, INC. -1.9%
LEGEND BIOTECH CORPORATION SPONSORED -1.9%
IONIS PHARMACEUTICALS, INC. -1.8%
DAY ONE BIOPHARMACEUTICALS, INC. -1.8%
ADMA BIOLOGICS, INC. -1.8%
INSMED INC -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY